$Creatv Bio’s LifeTracDx® Blood Test Utilized as Exploratory Biomarker in CytoDyn’s Phase 2 Study in Patients with Relapsed/Refractory Metastatic Colorectal Cancer$

Author: Creatv MicroTech, Inc.

Posted Date:

March 3, 2026

Creatv Bio’s LifeTracDx® Blood Test Utilized as Exploratory Biomarker in CytoDyn’s Phase 2 Study in Patients with Relapsed/Refractory Metastatic Colorectal Cancer

Creatv MicroTech, Inc.

March 3, 2026